On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
CTS implement the Bio-Rad Geenius HIV 1/2 supplemental assay on Monday September 21, 2020. The newly...
We received an updated WNV package insert; please note the manufacturer and license number has been ...
We sincerely hope to see you at this year’s AABB Annual Meeting in Boston, MA on October 12-16...